Home
>
National Drug Code (NDC)
>
Cefadroxil
Cefadroxil - 0093-4180-76 - (Cefadroxil)
Drug Information of Cefadroxil
| Product NDC: | 0093-4180 |
| Proprietary Name: | Cefadroxil |
| Non Proprietary Name: | Cefadroxil |
| Active Ingredient(s): | 250 mg/5mL & nbsp; Cefadroxil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cefadroxil
| Product NDC: | 0093-4180 |
| Labeler Name: | TEVA Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065278 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100202 |
Package Information of Cefadroxil
| Package NDC: | 0093-4180-76 |
| Package Description: | 50 mL in 1 BOTTLE (0093-4180-76) |
NDC Information of Cefadroxil
| NDC Code | 0093-4180-76 |
| Proprietary Name | Cefadroxil |
| Package Description | 50 mL in 1 BOTTLE (0093-4180-76) |
| Product NDC | 0093-4180 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cefadroxil |
| Dosage Form Name | POWDER, FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20100202 |
| Marketing Category Name | ANDA |
| Labeler Name | TEVA Pharmaceuticals USA Inc |
| Substance Name | CEFADROXIL |
| Strength Number | 250 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes |
